Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Rosemary and kalonji seeds can improve hair health and treat hair conditions.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Microneedling with clobetasol cream works better for hair regrowth in alopecia areata than clobetasol cream alone.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Certain black hairstyling practices increase the risk of traction alopecia, requiring better management and education.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

The study found specific hair and scalp patterns for different types of hair loss in Koreans, noting racial differences affect diagnosis.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Dupilumab effectively treated severe alopecia areata in a child.

Platelet-rich plasma helps improve skin and hair conditions.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.